ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESR01

Coordinated SLC12A3/SLC12A6/SL26A4 electroneutral transport pathways maintain K+ homeostasis and acid-base balance

Active
Institution
Vanderbilt University Medical Center, TN
Principal investigator
Eric J Delpire
Funding
$717K
Duration
2017–2027
Open portfolio

Moonbase score

Still being scored

Abstract

Alkaline diets and alkalemia have a profound impact on potassium homeostasis, but the underlying mechanisms remain poorly understood. Here we propose an innovative plan to close this significant knowledge gap, building on our recent discovery of a long sought-after electroneutral potassium transport pathway. Our data reveal that dietary alkaline loading stimulates the expression of the electroneutral KCl cotransporter, KCC3a (Slc12a6), in parallel with the Cl-/HCO3- exchanger, pendrin (Slc26a4), on the B- type intercalated cell apical membrane and the activation of the thiazide-sensitive sodium-chloride, NCC (Slc12a3), in the Distal Convoluted Tubule. Here we advance the overarching hypothesis that KCC3a is the long sought-after electroneutral potassium secretory pathway and propose the novel idea that coupling between KCC3a, pendrin, and NCC maintains potassium and acid-base balance in response to the consumption of alkaline and potassium-rich foods but drives potassium wasting in alkalosis. This new model will be rigorously tested by a multidisciplinary team of experts, combining state-of-the-art cellular biology and physiological phenotyping in novel genetically engineered mouse models. Aim 1 will test the hypothesis that KCC3a is activated in response to the consumption of alkaline diets and alkalosis to drive urinary potassium excretion. Intercalated-cell-specific KCC3 knockout mice will be investigated to a) test the contribution of KCC3 to potassium balance and b) to pendrin-mediated HCO3- secretion; c) elucidate the molecular mechanisms that underlie the regulation of KCC3 expression; c) test if KCC-specific inhibitors prevent the loss of K+ in alkalemia. Aim 2 will test the hypothesis that pendrin is co-activated with KCC3a to increase KHCO3 secretion. Pendrin knockout mice will be studied to determine: a) the contribution of pendrin to the regulation of KCC3a; and b) the physiologic consequences of uncoupling the transporters. We will also explore if KCC3a regulates pendrin through changes in pendrin transcription that involve changes in intracellular chloride. Aim 3 will test the hypothesis that alkalosis drives WNK-SPAK mediated phospho-activation of NCC to ensure electroneutral potassium bicarbonate secretion prevails over electrogenic potassium secretion. Newly developed DCT-specific loss and gain of SPAK mice and in vitro cell models will be examined to rigorously test this idea and explore the mechanism. In summary, this program of investigation should illuminate a new mechanism to explain how K+ and acid-base balance are preserved with the consumption of alkaline and potassium-rich foods, typical of the paleolithic and vegetarian diets. The investigation is also expected to change the textbook explanation of urinary potassium wasting in alkalosis, opening a new therapeutic horizon.

Research team

  • Eric J DelpirePI
  • Susan Marie WallPI
  • Paul A WellingPI

LOADING MOONBASE SCORE

R01NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESSpecial Emphasis Panel[ZRG1-KUDS-W(05)]wastingalkalinebalancefoodssecretionpotassiumdietsncc

Questions for Vanderbilt University Medical Center

Answered by the team behind this research.

Same researchers, same institution, same topic, scored first.